For tumor neoantigen prediction algorithm, there are many factors to be considered, including HLA typing, expression, mutation analysis, prediction peptide processing, TCR binding force, MHC affinity, PMHC stability, tumor neoantigen source,and so on (74, 75). This evidence concerns the gene HLA-C and neoplasm.